by The Economist
My articles My siteMy videosMy books
Follow on:LinkedINTwitterFacebookYoutubeAmazonGoogle +
| The race between covid-19 vaccines and variants is on. Alok Jha, The Economist’s science correspondent, and Natasha Loder, health policy editor, discuss what this means for the future Read more of our coverage on coronavirus: https://econ.st/3t1L6wx Listen to our daily podcast, Gamechangers, on mRNA technology: https://econ.st/38cSewe Listen to “The Jab” podcast from Economist Radio: https://econ.st/3yuETKF Watch our film about mandatory vaccines: https://econ.st/3DktD77 Which countries are considering a booster jab? https://econ.st/2WtrO6H Why are covid variants named using the Greek alphabet?https://econ.st/3gwA0u3 Can vaccines help solve environmental issues? https://econ.st/3mB89wE Why is the Delta variant the most dangerous mutation yet? https://econ.st/3sPLHBc What’s Britain’s strategy for mass vaccination? https://econ.st/3yjGgvs Where will you need proof of vaccination? https://econ.st/38dikiT How the pandemic has brought re-examination of intellectual-property rights: https://econ.st/3kkatFG Why are the unvaccinated at risk? https://econ.st/3kvjhZx Which vaccine is the most widely accepted for international travel? https://econ.st/3jjqBrD |
The Economist offers authoritative insight and opinion on international news, politics, business, finance, science, technology and the connections between them.
Tags: Featured,newsletter
